Medical and Pharmaceutical Replimune tanks on FDA concerns about its skin cancer therapy Shares slid by more than 37% at the intraday low on Tuesday Rowan Dunne3 days ago
Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
Cannabis Tilray’s medical cannabis division enters Panama with CBD shipments The nation's legal sector is small and growing slowly Rowan DunneJuly 13, 2026
Medical and Pharmaceutical ClearOne skyrockets from neurotech pivot, merger with Cortigent Cortigent uses brain and retina implant tech to help blind people navigate better Rowan DunneJuly 8, 2026
Technology Social tech company Triller closes 296% higher on SpaceX treasury strategy The investment follows financial turbulence and a 1-for-10 reverse stock split Rowan DunneJune 26, 2026
Medical and Pharmaceutical Tumour freezing specialist IceCure Medical skyrockets from latest successes The Israeli medtech company has been helping breast cancer patients avoid surgery Rowan DunneJune 18, 2026
AI and Autonomy Quantinuum targets USD$1.05B Nasdaq IPO in major quantum computing debut Quantinuum could achieve a fully diluted valuation near USD$12.7 billion Joseph MortonMay 27, 2026
Cannabis Cannabis telehealth operator Veri Medtech aims for Nasdaq uplisting Veri will be offering 3.75 million common shares at US$4 apiece Rowan DunneMay 11, 2026
Alternative Energy X-Energy IPO raises USD$1.02B as SMRs gain traction in AI era Tech giants and infrastructure developers have shifted toward nuclear energy to secure consistent power supply Joseph MortonApril 27, 2026
AI and Autonomy Wool shoe producer Allbirds soars on unexpected AI pivot Shares flew by over 575% on the back of the 'NewBird AI' rebrand news Rowan DunneApril 16, 2026